Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001353108.3(CEP63):c.110C>A(p.Ala37Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
CEP63 (HGNC:25815): (centrosomal protein 63) This gene encodes a protein with six coiled-coil domains. The protein is localized to the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells. Several alternatively spliced transcript variants have been found, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Nov 09, 2024
The c.110C>A (p.A37D) alteration is located in exon 4 (coding exon 2) of the CEP63 gene. This alteration results from a C to A substitution at nucleotide position 110, causing the alanine (A) at amino acid position 37 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);Loss of methylation at K40 (P = 0.0554);